Skip to Content

Join the 'Patiromer' group to help and get support from people like you.

Patiromer News

FDA Approves Supplemental New Drug Application for Veltassa Removing Boxed Warning Regarding Drug-Drug Interactions

Posted 30 Nov 2016 by

REDWOOD CITY, Calif., November 27, 2016 – Relypsa, Inc., a Vifor Pharma company, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) with important updates to the label of Veltassa (patiromer) for oral suspension. Veltassa’s label no longer includes a Boxed Warning regarding the separation of Veltassa and other oral medications. ...

FDA Approves Veltassa (patiromer) for Hyperkalemia

Posted 28 Oct 2015 by

October 21, 2015 – The U.S. Food and Drug Administration today approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high. “Too much potassium in the blood can lead to dangerous, even fatal, changes in heart rhythm,” said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Ren ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups


Patiromer Patient Information at